SPOTLIGHT: WHO: New sleep meds little better than old


A WHO analysis finds that new-generation sleep meds like Ambien and Lunesta have side effects that are "nearly as problematic" as older drugs such as Halcion, which was banned in some countries. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.